Marksans Pharma (MARKSANS) Stock Overview

Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.

MARKSANS Stock Information

Symbol

MARKSANS

Address

GrandeurMumbai, 400053India

Founded

Trading hours

Website

https://marksanspharma.com

Country

🇮🇳 India

Phone Number

91 22 4001 2000

Marksans Pharma (MARKSANS) Price Chart

Marksans Pharma Overview: Key Details and Summary

Stock data	2023	Change
Price	$2.69	N/A
Market Cap	$1.12B	N/A
Shares Outstanding	415.40M	1.49%
Employees	852.00	N/A
Shareholder Equity	17.65B	44.33%

Valuation	2023	Change
P/E Ratio	0.42	N/A
P/S Ratio	5.07	N/A
P/B Ratio	0.06	N/A

Growth	2023	Change
Return on Equity	0.0018	N/A

Earnings	2023	Change
Revenue	$220.36M	N/A
Earnings	$31.61M	N/A
EPS	6.41	N/A
Earnings Yield	2.38	N/A
Gross Margin	0.5019	N/A
Operating Margin	0.1692	N/A
Net income margin	0.1434	N/A

Financial Strength	2023	Change
Total Assets	$260.96M	N/A
Total Debt	$14.65M	N/A
Cash on Hand	$85.19M	N/A
Debt to Equity	0.0029	-29.35%
Cash to Debt	$5.82	85.85%
Current Ratio	$4.91	45.70%